6: Tanghetti EA; Tazarotene Stable Plaque Psoriasis Trial Study Group. An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients switched from treatment with calcipotriene +/- corticosteroid. Type: Clinical Trial, Evaluation Studies, Journal Article, Multicenter Study. The analysis of data from a subset of 166 patients who were switched from calcipotriene therapy, with or without a topical corticosteroid, to receive tazarotene plus a corticosteroid is reported here. The mean scores for overall severity of plaque psoriasis, plaque elevation, scaling, pruritus, and overall discomfort were reduced by 35, 41, 44, 45, and 40, respectively, compared with baseline levels at the time of switching therapy. Vulgaris: A Multicenter, Double-Blind, Randomized, Parallel-Group Study.
A large-scale observation study has been performed to evaluate how tazarotene is used to treat plaque psoriasis in everyday clinical practice and to elucidate whether the efficacy and tolerability of tazarotene treatment can be optimized through the adjunctive use of an emollient and/or a topical corticosteroid. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis. 39Tanghetti, EA and Tazarotene Stable Plaque Psoriasis Trial study group. Tazarotene is a pro-drug of tazarotenic acid, a receptor-selective retinoid, which has shown efficacy in the treatment of these disorders. The tazarotene + mometasone furoate group had significantly greater and more rapid efficacy, and a more prolonged effect post-treatment.
Children 12 years of age: In clinical studies, therapy did not exceed 12 weeks. 1 tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. 32 Tanghetti A.E. Tazarotene Stable Plaque Psoriasis Trial Study Group. Psychodermatologic Effects of Atopic Dermatitis and Acne: A Review on Self-Esteem and Identity. Koo J. Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials. Supraerythemogenic excimer laser in combination with clobetasol spray and calcitriol ointment for the treatment of generalized plaque psoriasis: Interim results of an open label pilot study.